Summary of Purpose
Ischemic stroke, which is due to the occlusion of a cerebral blood vessel, comprises nearly 90% of all strokes. Currently, reperfusion of the salvageable tissue via thrombolytic drug or endovascular treatment is the most effective strategy to reduce brain damage. However, after recanalizing the occluded vessels, subsequent reperfusion injury is inevitable. It may not only weaken the therapeutic effects of timely...Read More →
The following dates are available for this trial. Trial information last updated on 7 February 2017.
|1 Mar 2017||3 Feb 2017||1 Jun 2018||1 Jan 2019||1 Feb 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|